Literature DB >> 7567261

Late and acute adverse reactions to iohexol in a pediatric population.

R Mikkonen1, T Kontkanen, L Kivisaari.   

Abstract

The purpose of this study was to determine the incidence of acute and late reactions after contrast-medium injection in the Finnish paediatric population. From March 1989 to November 1990, 321 children under 19 years of age were examined with a nonionic contrast medium, iohexol, for urography and CT. The follow-up time for late reactions was up to 24 h after the contrast-medium injection. The return rate for the questionnaires given to patients to record their reactions was 73.2%. Acute adverse reaction was noted in 1.9% of the patients, with the most frequent reactions being in the weight range 24-40 kg. Asthma and previous reaction to contrast medium are risk factors for acute reaction. Late reactions were found in 6.2% of the patients, most frequently in children weighing under 24 kg.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7567261     DOI: 10.1007/BF02021700

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  19 in total

1.  Clinical survey of adverse reactions to contrast media.

Authors:  H Katayama; T Tanaka
Journal:  Invest Radiol       Date:  1988-09       Impact factor: 6.016

2.  Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.

Authors:  H Katayama; K Yamaguchi; T Kozuka; T Takashima; P Seez; K Matsuura
Journal:  Radiology       Date:  1990-06       Impact factor: 11.105

3.  Adverse reactions to contrast agents. Scope of problem.

Authors:  G Ansell
Journal:  Invest Radiol       Date:  1970 Nov-Dec       Impact factor: 6.016

4.  Nonionic versus ionic contrast media in intravenous urography: clinical trial in 1,000 consecutive patients.

Authors:  B F Jacobsson; H Jorulf; M S Kalantar; D L Narasimham
Journal:  Radiology       Date:  1988-06       Impact factor: 11.105

Review 5.  Radiocontrast reactions.

Authors:  P Lieberman; R L Siegle; G Treadwell
Journal:  Clin Rev Allergy       Date:  1986-05

6.  Tolerance and excretion of iohexol after intravenous injection in healthy volunteers. Preliminary report.

Authors:  T Aakhus; S C Sommerfelt; H Stormorken; K Dahlström
Journal:  Acta Radiol Suppl       Date:  1980

7.  The current status of reactions to intravenous contrast media.

Authors:  G Ansell; M C Tweedie; C R West; P Evans; L Couch
Journal:  Invest Radiol       Date:  1980 Nov-Dec       Impact factor: 6.016

8.  Iohexol and metrizamide for urography in infants and children.

Authors:  G Stake; B Smevik
Journal:  Invest Radiol       Date:  1985 Jan-Feb       Impact factor: 6.016

9.  Mortality during excretory urography: Mayo Clinic experience.

Authors:  G W Hartman; R R Hattery; D M Witten; B Williamson
Journal:  AJR Am J Roentgenol       Date:  1982-11       Impact factor: 3.959

10.  Iohexol compared with diatrizoate in pediatric urography.

Authors:  H Jorulf
Journal:  Acta Radiol Suppl       Date:  1983
View more
  3 in total

1.  Evaluation of image quality and radiation dose of thoracic and coronary dual-source CT in 110 infants with congenital heart disease.

Authors:  Moez Ben Saad; Adela Rohnean; Anne Sigal-Cinqualbre; Ghazal Adler; Jean-Francois Paul
Journal:  Pediatr Radiol       Date:  2009-03-25

2.  Patterns of intravenous contrast material use and corticosteroid premedication in children--a survey of Society of Chairs of Radiology in Children's Hospitals (SCORCH) member institutions.

Authors:  Andrew T Trout; Jonathan R Dillman; James H Ellis; Richard H Cohan; Peter J Strouse
Journal:  Pediatr Radiol       Date:  2011-05-19

Review 3.  Radiocontrast Media Hypersensitivity Reactions in Children.

Authors:  Francesca Saretta; Silvia Caimmi; Francesca Mori; Annamaria Bianchi; Paolo Bottau; Giuseppe Crisafulli; Fabrizio Franceschini; Lucia Liotti; Claudia Paglialunga; Giampaolo Ricci; Carlo Caffarelli
Journal:  Medicina (Kaunas)       Date:  2022-04-05       Impact factor: 2.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.